Neogen Chemicals: Rs 161 cr preferential issue funds fully utilized, no deviation

Neogen Chemicals raised Rs 161 crore through a preferential issue of equity shares on April 18, 2026. CRISIL Ratings, the appointed monitoring agency, confirmed in its final report for the quarter ended June 30, 2026 that the entire amount has been fully utilized with no deviation from stated objects. Rs 100 crore was invested in subsidiary Neogen Ionics Limited via CCDs for capital expenditure at the Pakhanjan project. Rs 21 crore was used for working capital and Rs 40 crore for general corporate purposes, both applied to adjust the cash credit facility with SBI.